Drug Target Review

Drug Target Review is the leading FREE publication for the drug discovery industry, promoting the latest research, developments & technology.

[Drug Target Review @DrugTargetRev]

AD| Is low DNA input stalling your research? The ThruPLEX® DNA-Seq Kit turns picograms of DNA into high-quality sequencing libraries!

Optimized for genomic DNA from cells/tissues, cell-free DNA, and outputs from ChIP or CUT&RUN.

Learn more: https://t.co/xUiIWxuFOP

[Drug Target Review @DrugTargetRev]

AD| What if you could analyze genomic and transcriptomic data from rare cells like CTCs?

The Embgenix™ GT-omics Kit from Takara Bio USA, Inc., makes it possible—generate Illumina®-ready DNA-seq & RNA-seq from a single sample.
https://t.co/xtInfThkJc

[Drug Target Review @DrugTargetRev]

AD| Struggling with critical, low-input samples for long-read RNA-seq? advancements have improved long-read RNA-seq, but these methods require a large amount of input RNA. New data demonstrates previously unknown transcriptomic, using SMART-Seq® mRNA : https://t.co/FYHl0H7w47

[Drug Target Review @DrugTargetRev]

AD| Excited to use NGS technologies to detect B-cell receptor or T-cell receptor clonotypes, but unsure how to get started? Download this educational guide from @TakaraBioUSA
👉 https://t.co/iJNBM3RBV3

[Drug Target Review @DrugTargetRev]

AD ll T-cell receptor detection accelerate cancer therapy
development? Accurate analysis of TCR repertoires is critical for identifying
TCR biomarkers With SMART-Seq® Mouse TCR 1–10 ng of total RNA to identify biomarkers with UMI-powered accuracy.
https://t.co/2mDxie9kCF

[Drug Target Review @DrugTargetRev]

AD lSuccessful
in vitro transcription and translation for therapeutic applications requires
generating highly optimized DNA templates.
https://t.co/GCadWXmBpm

[Drug Target Review @DrugTargetRev]

AD lSuccessful
in vitro transcription and translation for therapeutic applications requires
generating highly optimized DNA templates.
https://t.co/GCadWXmBpm

[Drug Target Review @DrugTargetRev]

AD | Are you struggling with lentiviral transduction? Takara Bio has curated expert tips on 5 critical steps in the workflow including vector cloning, virus titration, and transduction. Download the infographic for quick reference: https://t.co/eNJeFxD6g2

[Drug Target Review @DrugTargetRev]

📢 Don’t Miss Our Latest Report: Beyond the Lab – Stem Cell Research. Stem cell research is redefining how we treat disease. From tackling inflammatory bowel disease to unlocking age-related therapies, the possibilities are groundbreaking. https://t.co/yqWJHVDfcC

[Drug Target Review @DrugTargetRev]

Read Our Latest Report on Stem Cell Research! What if the key to treating cancer, diabetes, and aging lies within our own cells? Our new report, Beyond the Lab: Stem Cell Research, dives into the latest breakthroughs. https://t.co/yqWJHVDfcC

[Drug Target Review @DrugTargetRev]

Read Our Latest Report: Beyond the Lab – Stem Cell Research 🚀 Stem cell research is transforming healthcare. From regenerative medicine to groundbreaking therapies for chronic diseases, the potential is limitless. https://t.co/yqWJHVDfcC

[Drug Target Review @DrugTargetRev]

AD | The Shasta™ Single Cell System for large-scale #singlecell #NGS profiling is now available from Takara Bio USA! Sign up for priority access to case studies, application notes, and other resources: https://t.co/9r1TCWodTP

[Drug Target Review @DrugTargetRev]

AD| Explore the new NexusXp interactive pavilion at #SLAS2025! Discover actionable insights to automate your lab, from Design–Make–Test–Analyze, and enable effective drug discovery. Separate registration required. https://t.co/5FOnTIFi21

[Drug Target Review @DrugTargetRev]

🆕 New report
Beyond the lab: antibodies
Explore pioneering advancements in antibody-based therapies that target immune pathways to combat challenging diseases from
🥼Alexander Schinagl
🥼Ellen Capon
🥼Søren Bregenholt

Download and discover today 🔍 https://t.co/kavzpsSi7R

[Drug Target Review @DrugTargetRev]

AD | 3 weeks to go!

Wrap up 2024 with novel insights into covalent screening, developing novel warheads for cysteine & beyond, & preclinical progression for hard-to-drug targets at the #Covalent #DrugDiscovery & Development Summit

Event brochure: https://t.co/MtgKq9wYPy

[Drug Target Review @DrugTargetRev]

Beyond the lab: antibodies 🧪
A new report covering exclusive content:
🧪Combining precision bispecific antibodies with targeted radiotherapy
🧪Detecting antibodies unique to stage I and II melanoma patients 

Click the link to discover more today👉 https://t.co/kavzpsSi7R

[Drug Target Review @DrugTargetRev]

AD | Wondering who's presenting at the Covalent Drug Discovery & Development Summit?

Here's a sneak preview of the 22-strong world-class speaker faculty!🔎

See the full list and their sessions in the program here: https://t.co/NaWhsezVgq

#Covalent #DrugDiscovery

[Drug Target Review @DrugTargetRev]

🆕New report!
Beyond the lab:🦠antibodies
Highlighting recent breakthroughs across various fields including:
🔹Cancer research
🔹Neuroscience
🔹Antibody based therapies
Download and discover today 🔎 https://t.co/z2VPOIjwQC

[Drug Target Review @DrugTargetRev]

AD | Join 100+ global covalency leaders to:

🌟 Balance reactivity and sensitivity
🌟 De-risk the ligandability of alternative residues
🌟 Tacke PKPD disconnects and efficiency bottlenecks

Explore 3 days of sessions here:https://t.co/PQCH357ytm

#Covalent #DrugDiscovery

[Drug Target Review @DrugTargetRev]

AD | Seeking to unlock the #undruggables? Look no further than the #Covalent #DrugDiscovery & Development Summit, uniting chemical biology, proteomics, medicinal chemistry & drug discovery specialists this December!

Download program: https://t.co/pz4lyQP7Lw

@Undruggable